A Study of Olaparib Prior to Surgery and Chemotherapy in Ovarian, Primary Peritoneal, and Fallopian Tube Cancer

Mise à jour : Il y a 5 ans
Référence : NCT02489006

Femme Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

This is a study that will look at the effects and how useful investigational drug olaparib is as a neoadjuvant treatment (treatment given as to shrink a tumor before the main treatment) prior to surgery in patients with recurrent ovarian, primary peritoneal or fallopian tube cancer.


Critère d'inclusion

  • Ovarian Cancer,Fallopian Tube Cancer,Neoadjuvant Treatment,Debulking Surgical Procedures

Liens